The "Next Generation Immunotherapies" conference brings together leading experts in the field of cancer immunotherapy to explore cutting-edge approaches in adoptive cell therapies, T cell engagers, next-generation antibodies, therapeutic vaccines, and immunocytokines. This comprehensive program features presentations on innovative technologies such as invariant natural killer T cells, gamma delta T cells, MAIT cell engagers, and antibody-cytokine fusion proteins. Attendees will gain insights into the latest advancements in cancer treatment strategies, from allogeneic cell therapies to HLA-agnostic T cell receptors and novel cytokine delivery methods.